Kershaw, Cook & Talley is investigating the Alere InRatio® PT/INR Monitor System recall. The Alere InRatio PT/INR Monitor System is a device designed for individuals taking a prescription anticoagulation medication (like Coumadin or warfarin) to self-test their PT/INR, or blood clotting levels. According to the Food and Drug Administration (FDA), the recall was issued due to certain cases in which an INRatio and INRatio2 PT/INR Monitor system provided a falsely low INR reading. The FDA recommends patients with any of the following conditions stop using the device:
Patients with any condition requiring the use of the device should immediately notify their health care professional. It is recommended the patient transition to a laboratory INR method for monitoring their INR and anticoagulation therapy.
If you, or a loved one, use the Alere INR Home Monitoring, contact an experienced personal injury attorney at Kershaw, Cook & Talley.